Cannabis Lies Vol. 23: The IQ Lie

Filed Under: Cannabis Lies

---

Eight IQ points became the cleanest number in modern cannabis propaganda. The study behind it was real, but the universal warning built from it was not.

Eight IQ points escaped a New Zealand birth study in 2012 and spent the next fourteen years posing as the standard cost of adolescent cannabis use.

The number sounded clinical, frightened readers and survived translation from paper to scare page. Headlines stripped away diagnostic thresholds, the tiny high-exposure subgroup, and the role of abstinence. They also dropped socioeconomic factors and the difference between association and individual destiny, leaving a fake equation: cannabis went in, and eight points came out.

That version still lives on official federal websites.

SAMHSA says marijuana “can cause permanent IQ loss of as much as 8 points” when use begins young and claims the points do not return after quitting.

The Drug Enforcement Administration says a New Zealand study demonstrated that heavy marijuana smoking in the teen years resulted in an average loss of eight IQ points.

Both statements descend from a serious study without giving readers enough information to understand what it found.

The lie is not that cannabis intoxication can impair learning, concentration, and short-term recall. Heavy, persistent use deserves scrutiny, especially when it begins during adolescence. The deception begins when one alarming group average becomes a standard penalty, and the public is invited to believe cannabis permanently makes people stupid.

Science found a risk signal in a small and unusually persistent group. Prohibition printed a receipt for brain damage.

The famous number came from the Dunedin Multidisciplinary Health and Development Study, a longitudinal project that followed 1,037 people born in Dunedin, New Zealand, in 1972 and 1973. Participants completed intelligence testing during childhood and again at age 38. Researchers assessed cannabis use and dependence at ages 18, 21, 26, 32 and 38.

Because Dunedin tested participants before most cannabis exposure and again at 38, researchers could examine change instead of merely comparing consumers with nonconsumers at one moment.

Published in the Proceedings of the National Academy of Sciences, the 2012 paper reported an association between persistent cannabis use and neuropsychological decline. Among 41 participants who reported regular use at three or more assessment waves, average IQ fell by about five points. The eight-point headline came from 23 adolescent-onset participants with at least three cannabis-dependence diagnoses.

The headline rested on 23 people. Their result deserves attention, but its limits belong beside the number. The figure did not represent everyone who used cannabis as a teenager, tried a joint, used weekly or began as an adult. It described the mean change in the study’s most severe adolescent-onset dependence group.

---

---

The study’s lead author, Madeline Meier, made the scale plain in 2019 testimony to the United States Senate Caucus on International Narcotics Control. Only about 2 percent of the entire Dunedin cohort became adolescent-onset persistent cannabis users. Participants who used cannabis for a shorter period during adolescence showed only weak evidence of a three-point decline. Adult-onset persistent users did not show IQ decline in the 2012 analysis.

Meier described the cognitive deficits in heavy users as subtle and listed major unanswered questions about dose, frequency, age of onset, duration, potency, recovery with abstinence, and individual susceptibility.

Those questions define the boundaries of the evidence.

The exposure was far removed from casual experimentation. Researchers measured persistence through repeated dependence diagnoses or regular use across multiple waves, defining regular as four or more days per week. Adolescent onset meant dependence before 18 or weekly use before 18, depending on the analysis. Those driving the strongest result had established a heavy pattern that continued for years.

Potency further complicates the translation. Meier testified that the cohort had access to cannabis containing about 3.5 percent THC. Modern products may carry different risks, while consumers may also reduce the amount used as potency rises. Meier said researchers needed exposure measures that captured dose, frequency, product type, and duration.

Federal messaging kept the number and abandoned the conditions. The DEA version says “heavy smoking” by teens caused an average eight-point loss but omits the 23-person subgroup and its dependence history. The adult-onset result and unresolved causal questions disappear too.

On the same page, the agency cites Smart Approaches to Marijuana, an anti-legalization organization, for sweeping claims about states with legal cannabis. A law enforcement agency has built a youth science page where a politically committed advocacy group helps furnish the facts.

SAMHSA goes broader than the study by omitting heavy or persistent use. Its warning presents eight points as a durable biological tariff for starting young.

The Centers for Disease Control and Prevention offers a more careful account. Its guidance says recent use can immediately affect thinking and reaction time, including attention, memory, and coordination. Long-term effects on attention and learning may endure or possibly become permanent, but more research is needed. The CDC says outcomes vary with potency, frequency, and age at first use. Other substances and background factors further complicate the picture.

Alongside the Dunedin paper, the CDC cites a later twin study that complicated the causal story.

That 2016 analysis of two longitudinal twin cohorts found that adolescents who used marijuana scored lower on some measures and experienced declines in certain areas over time. Yet the pattern did not support a simple neurotoxic explanation. Cannabis-using twins did not show significantly greater IQ decline than their abstinent siblings. Because twins share much of their genetics and family environment, that comparison suggested that common background factors could help explain why adolescent cannabis use and lower cognitive performance travel together.

Another prospective British cohort study published in 2016 found no association between adolescent cannabis use and lower IQ or poorer educational performance after adjustment for relevant confounders. These studies did not prove cannabis harmless. They showed that family background, school engagement and mental health can influence cannabis use and cognitive performance. Other drug use, initial ability and social disadvantage can further muddy the association.

The Dunedin result faced a direct challenge in 2013. Economist Ole Rogeberg argued in PNAS that socioeconomic differences could produce the observed association. His modeling proposed that social class, education, and different cognitive trajectories might account for an apparent cannabis effect.

---

---

Rogeberg tested an alternative explanation, and the original authors answered with cohort data showing that socioeconomic status did not explain the decline. That is scientific scrutiny, not a settled verdict.

Public propaganda reported the opening argument as a verdict and skipped the cross-examination. A 2018 JAMA Psychiatry systematic review and meta-analysis combined 69 studies, 2,152 frequent or heavy cannabis users and 6,575 comparison participants. The association between cannabis use and cognitive performance was statistically significant but small.

Across 15 studies involving 928 participants that required more than 72 hours of abstinence, the effect was very small and not statistically different from zero.

That finding cannot establish that every cognitive effect disappears after three days. Abstinence was not randomly assigned, the underlying studies differed, and the heaviest long-term patterns remain difficult to capture. Still, it raises an obvious problem for the permanent-damage slogan. Some deficits measured in cannabis research may reflect recent intoxication or withdrawal rather than a fixed loss of intellectual ability.

A 2021 meta-analysis of longitudinal studies reached a less reassuring but still measured conclusion. Across seven cohorts involving 808 cannabis-exposed participants and 5,308 controls, frequent or dependent youth use was associated with an average decline of approximately two IQ points. That pooled association was far below the federal eight-point warning and did not predict a guaranteed loss for every exposed person.

Research in adults carries the same warning against cartoon conclusions. The CARDIA study followed thousands of Americans into middle age and assessed cognitive function in 3,385 participants after 25 years. After extensive adjustment, cumulative cannabis exposure was associated with worse verbal memory.

Every five “marijuana-years,” defined as daily use for five years or an equivalent cumulative amount, corresponded to about one fewer word recalled from a list of 15. Adjusted associations with processing speed and executive function did not remain significant.

Credible risk communication identifies who was studied, what exposure meant and how large the association was.

“Marijuana makes you dumb” identifies nothing except the speaker’s preferred stigma.

The National Academies’ 2017 review placed the distinction in unusually clear terms. It found moderate evidence linking acute cannabis use with impairment in learning, memory and attention. Evidence connecting sustained abstinence with continuing impairment in those domains was only limited. The scientific record was strongest for what happens around recent use and weaker for what remains after it.

A 2022 American Journal of Psychiatry follow-up assessed participants at age 45. Researchers identified 86 long-term users who, at age 45, used cannabis at least weekly or met dependence criteria at that age and who had also used at least weekly during an earlier assessment period.

Their median use at 45 was 300 days in the previous year. Nearly two-thirds used on four or more days per week, and 72 percent had met dependence criteria at least once.

The long-term group showed a mean childhood-to-midlife decline of 5.5 IQ points, along with poorer learning and processing speed and more memory and attention problems reported by people who knew them. Recreational midlife users and people who had quit showed smaller deficits or none. Researchers also found smaller hippocampal volume in the long-term group, although that difference did not statistically explain the cognitive deficits.

That result strengthens concern around persistent, high-frequency use and the case against lumping all consumers together. Researchers separated long-term users from recreational users and quitters because exposure pattern matters. Federal slogans collapse those categories until risk becomes a weapon.

Long observational studies cannot randomly assign decades of heavy cannabis use. They must account for confounding and self-report error while participants age, leave the study, or change products. Childhood testing and twin comparisons strengthen the evidence without creating laboratory certainty.

IQ also requires restraint. The score samples several cognitive abilities under standardized conditions but does not measure a person’s moral worth or full potential. A group mean cannot diagnose an individual, and scores can move with education, health, stress, and sleep.

Once prohibition gets hold of IQ, the number becomes character evidence. That is why the claim travels so well in legislative rooms.

In 2023 written testimony opposing Ohio Senate Bill 9, the Prevention Action Alliance cited an eight-point IQ loss while lawmakers considered a broader overhaul of the state’s medical marijuana program. A result published in 2012 from 23 persistent adolescent-onset users in New Zealand had become ammunition in an American policy fight eleven years later.

---

---

The journey makes no scientific sense but perfect political sense.

Claims about damaged intelligence do more than warn young people. They recast patients as confused marks for an industry and adult consumers as too addled to understand policy. Activists become selfish drug users arguing against their own impairment, while communities harmed by enforcement are blamed on the plant. By the time those people object, the stereotype has already explained why nobody should listen.

The insult predates Dunedin. The 1972 Shafer Commission found the social response to marijuana disproportionate, yet the Nixon administration rejected its recommendation to remove criminal penalties for private possession. Fourteen years later, Reagan called for changing national attitudes toward illegal drugs. The eight-point claim later gave that contempt a scientific costume.

Honest policy should encourage young people to delay use and tell parents which patterns carry the greatest risk. Consumers need practical guidance about potency, frequency and mixing substances, while people who want to cut back deserve help without humiliation. None of that requires pretending every teenager who used cannabis permanently surrendered a fixed quantity of intelligence.

The honest conclusion is narrower and more useful: acute cannabis use can impair attention, learning and memory, while persistent heavy use beginning in adolescence is associated with a greater risk of lasting cognitive problems. What lasts, why it happens, and who is affected remain contested because results change with study design, exposure level, and abstinence. Casual use, adult-onset use, and long-term dependence are not interchangeable categories.

Prohibition flattened all of that into eight points because nuance does not arrest anyone, protect a federal budget or disqualify a patient at a hearing. The lie never required cannabis to be harmless: officials needed only one frightening number stripped from the 23-person subgroup and the years of persistent dependence that gave it meaning.

Eight points did not prove every cannabis consumer had surrendered part of their intellect; it gave prohibition a scientific-sounding reason to stop listening to them.

---

_{^{©2026 Pot Culture Magazine. All rights reserved. This content is the exclusive property of Pot Culture Magazine and may not be reproduced, distributed, or transmitted in any form or by any means without prior written permission from the publisher, except for brief quotations in critical reviews.}}

---